Avandia, approved by the FDA in 1999, was developed to help control blood sugar in adults with Type 2 Diabetes. The drug is used by millions worldwide.

In 2007, The New England Journal of Medicine detailed an analysis of clinical trials suggesting that the drug significantly increases the risk of heart attacks and cardiovascular death. The study was conducted by doctors at the renowned Cleveland Clinic and was published on May 21, 2007.

The trials compared patients taking Avandia with those not using the drug. The results indicate that Avandia users had an increase of cardiac-related deaths by 64 percent and 43 percent increase in heart attacks.

On May 21, 2007, the U.S. Food and Drug Administration said patients taking Avandia, especially those with heart disease or at high risk of heart attack, should talk to their doctor about the risks. Since the drug was approved, the FDA has monitored several heart-related adverse events associated with Avandia, such as fluid retention, edema and congestive heart failure.

If you or someone you know have/has taken Avandia and may be suffering or injured - Please feel free to fill out our Confidential Questionnaire Form or CALL US AT 1-888-766-2690